SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16540554
Source:
http://linkedlifedata.com/resource/pubmed/id/16540554
Search
Subject
(
87
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003873
,
umls-concept:C0008976
,
umls-concept:C0030705
,
umls-concept:C0036043
,
umls-concept:C0242708
,
umls-concept:C0332293
,
umls-concept:C0443252
,
umls-concept:C0717758
,
umls-concept:C0720193
pubmed:issue
12
pubmed:dateCreated
2006-11-19
pubmed:abstractText
To evaluate the long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-10075615
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-10606358
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11096165
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11409115
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11550957
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-11762947
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-12115173
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-12794818
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-12949498
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-14156622
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-1485814
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-15001324
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-15829572
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-15996057
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-1976811
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-2509559
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-3970041
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-6722416
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-7540941
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-8147925
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-8507213
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-8945568
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-9219699
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-9811046
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16540554-9920948
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor
,
http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-4967
pubmed:author
pubmed-author:DougadosMM
,
pubmed-author:Etanercept Study 301 Investigators
,
pubmed-author:GaubitzMM
,
pubmed-author:KlareskogLL
,
pubmed-author:MalaiseMM
,
pubmed-author:Rodriguez-ValverdeVV
,
pubmed-author:WajdulaJJ
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1578-84
pubmed:dateRevised
2010-9-14
pubmed:meshHeading
pubmed-meshheading:16540554-Antirheumatic Agents
,
pubmed-meshheading:16540554-Arthritis, Rheumatoid
,
pubmed-meshheading:16540554-Blood Sedimentation
,
pubmed-meshheading:16540554-C-Reactive Protein
,
pubmed-meshheading:16540554-Double-Blind Method
,
pubmed-meshheading:16540554-Drug Administration Schedule
,
pubmed-meshheading:16540554-Female
,
pubmed-meshheading:16540554-Follow-Up Studies
,
pubmed-meshheading:16540554-Humans
,
pubmed-meshheading:16540554-Immunoglobulin G
,
pubmed-meshheading:16540554-Male
,
pubmed-meshheading:16540554-Middle Aged
,
pubmed-meshheading:16540554-Neoplasms
,
pubmed-meshheading:16540554-Opportunistic Infections
,
pubmed-meshheading:16540554-Receptors, Tumor Necrosis Factor
,
pubmed-meshheading:16540554-Respiratory Tract Infections
,
pubmed-meshheading:16540554-Severity of Illness Index
,
pubmed-meshheading:16540554-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs.
pubmed:affiliation
Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Stockholm 17176, Sweden. Lars.Klareskog@medks.ki.se
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study